{"id":"https://openalex.org/W97193536","doi":"https://doi.org/10.3201/eid1011.040797_06","title":"New Concepts for Vaccines1","display_name":"New Concepts for Vaccines1","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W97193536","doi":"https://doi.org/10.3201/eid1011.040797_06","mag":"97193536"},"language":"en","primary_location":{"id":"doi:10.3201/eid1011.040797_06","doi":"https://doi.org/10.3201/eid1011.040797_06","is_oa":true,"landing_page_url":"https://doi.org/10.3201/eid1011.040797_06","pdf_url":null,"source":{"id":"https://openalex.org/S189281586","display_name":"Emerging infectious diseases","issn_l":"1080-6040","issn":["1080-6040","1080-6059"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315581","host_organization_name":"Centers for Disease Control and Prevention","host_organization_lineage":["https://openalex.org/P4310315581"],"host_organization_lineage_names":["Centers for Disease Control and Prevention"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Emerging Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.3201/eid1011.040797_06","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064345498","display_name":"Trudy V. Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Trudy V. Murphy","raw_affiliation_strings":["Centers for Disease Control and Prevention, Atlanta, Georgia, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA;","institution_ids":["https://openalex.org/I1289490764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019152388","display_name":"Gary O. Dubin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Dubin","raw_affiliation_strings":["GlaxoSmithKline, King of Prussia, Pennsylvania, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, King of Prussia, Pennsylvania, USA;","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036112915","display_name":"Robert B. Belshe","orcid":"https://orcid.org/0000-0003-0940-7213","observed_orcids":["https://orcid.org/0000-0003-0940-7213"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert B. Belshe","raw_affiliation_strings":["St. Louis University Health Sciences Center, St. Louis, Missouri, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Louis University Health Sciences Center, St. Louis, Missouri, USA;","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055066987","display_name":"Thomas P. C. Monath","orcid":"https://orcid.org/0000-0001-7509-4599","observed_orcids":["https://orcid.org/0000-0001-7509-4599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas P. Monath","raw_affiliation_strings":["Acambis Inc., Cambridge, Massachusetts, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acambis Inc., Cambridge, Massachusetts, USA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053233554","display_name":"Irene B. Glowinski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene B. Glowinski","raw_affiliation_strings":["National Institutes of Health, Bethesda, Maryland, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health, Bethesda, Maryland, USA;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024907629","display_name":"Susan A. Daniels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan A. Daniels","raw_affiliation_strings":["National Institutes of Health, Bethesda, Maryland, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health, Bethesda, Maryland, USA;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083356553","display_name":"Joel C. Gaydos","orcid":"https://orcid.org/0000-0002-4293-5926","observed_orcids":["https://orcid.org/0000-0002-4293-5926"]},"institutions":[{"id":"https://openalex.org/I1330347796","display_name":"United States Department of Defense","ror":"https://ror.org/0447fe631","country_code":"US","type":"government","lineage":["https://openalex.org/I1330347796"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel C. Gaydos","raw_affiliation_strings":["Department of Defense Global Emerging Infections Surveillance and Response System, Silver Spring, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Defense Global Emerging Infections Surveillance and Response System, Silver Spring, Maryland, USA","institution_ids":["https://openalex.org/I1330347796"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5064345498"],"corresponding_institution_ids":["https://openalex.org/I1289490764"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00575786,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"11","first_page":"e29","last_page":"e29"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.6503999829292297,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.6503999829292297,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.15520000457763672,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.094200000166893,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vaccines","display_name":"vaccines","score":0.8119999766349792},{"id":"https://openalex.org/keywords/vaccine-development","display_name":"vaccine development","score":0.6859999895095825}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7680152654647827},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.6256415843963623},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5923188924789429},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5238369107246399},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5082356333732605},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.47247692942619324},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.46622800827026367},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4419829845428467},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3319306969642639},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3059579133987427},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.28210175037384033}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3201/eid1011.040797_06","doi":"https://doi.org/10.3201/eid1011.040797_06","is_oa":true,"landing_page_url":"https://doi.org/10.3201/eid1011.040797_06","pdf_url":null,"source":{"id":"https://openalex.org/S189281586","display_name":"Emerging infectious diseases","issn_l":"1080-6040","issn":["1080-6040","1080-6059"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315581","host_organization_name":"Centers for Disease Control and Prevention","host_organization_lineage":["https://openalex.org/P4310315581"],"host_organization_lineage_names":["Centers for Disease Control and Prevention"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Emerging Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2334744","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3329052","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3329052","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3329052","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Emerg Infect Dis","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3f10a70907b24fc3b7dc249235c2baaf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3f10a70907b24fc3b7dc249235c2baaf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Emerging Infectious Diseases, Vol 10, Iss 11, Pp - (2004)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3201/eid1011.040797_06","doi":"https://doi.org/10.3201/eid1011.040797_06","is_oa":true,"landing_page_url":"https://doi.org/10.3201/eid1011.040797_06","pdf_url":null,"source":{"id":"https://openalex.org/S189281586","display_name":"Emerging infectious diseases","issn_l":"1080-6040","issn":["1080-6040","1080-6059"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315581","host_organization_name":"Centers for Disease Control and Prevention","host_organization_lineage":["https://openalex.org/P4310315581"],"host_organization_lineage_names":["Centers for Disease Control and Prevention"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Emerging Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8199999928474426,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1964884301","https://openalex.org/W4236081280","https://openalex.org/W4213139855","https://openalex.org/W4235377428","https://openalex.org/W1484324749","https://openalex.org/W2050973341","https://openalex.org/W2055721074","https://openalex.org/W2087678348","https://openalex.org/W4240807412","https://openalex.org/W4230131524"],"abstract_inverted_index":{"New":[0,304],"technologies":[1],"have":[2,131,203,512],"created":[3],"opportunities":[4],"to":[5,100,135,274,285,298,306,382,402,415,452],"develop":[6],"novel":[7,39],"vaccines,":[8,313],"including":[9],"vaccines":[10,86,179,511],"for":[11,23,112,178,214],"sexually":[12,181],"transmitted":[13,182],"infections,":[14],"influenza,":[15],"and":[16,45,68,80,104,124,164,170,173,194,211,237,243,297,322,326,347,365,444,515],"arthropodborne":[17],"viruses.":[18,279,332,357],"A":[19,116,224],"GlaxoSmithKline":[20],"(GSK)":[21,130],"vaccine":[22,58,94,120,129,151,309,385,391,421],"genital":[24,64],"herpes":[25,29,65],"combines":[26],"a":[27,38,144],"recombinant":[28,316,398],"simplex":[30,78],"virus":[31,85],"(HSV)":[32],"glycoprotein":[33],"D":[34,472],"(gD)":[35],"with":[36,55,63,138,233,371,463],"AS04,":[37],"proprietary":[40],"adjuvant":[41],"containing":[42],"aluminum":[43],"salts,":[44],"3-deacylated":[46],"monophosphoryl":[47],"lipid":[48],"A.":[49],"Two":[50],"recently":[51,132],"completed":[52],"efficacy":[53,147],"trials":[54],"the":[56,139,149,186,207,248,253,272,287,301,343,350,368,380,384,388,411,420,453,457,475,478,481,487],"gD-AS04":[57],"demonstrated":[59],"protection":[60,167],"against":[61,102,168,180],"infection":[62,137],"in":[66,74,88,166,206,271,355,387,518],"HSV-1":[67],"-2":[69],"seronegative":[70,75],"women,":[71],"but":[72],"not":[73,429],"men.":[76],"Herpes":[77],"DNA":[79,418],"live":[81,198,424],"attenuated":[82,199,249],"or":[83,225,400,405,427,500],"replication-impaired":[84],"are":[87,264,483],"early":[89],"development.":[90],"Human":[91],"papillomavirus":[92],"(HPV)":[93],"uses":[95],"L1":[96,118,127],"virus-like":[97],"particles":[98],"(VLP)":[99],"immunize":[101],"HPV-16":[103,117,172],"-18,":[105],"two":[106],"oncogenic":[107],"types":[108],"of":[109,188,201,222,252,291,315,320,330,336,345,353,377,390,396,413,434,459,480,489,507],"HPV":[110,141],"responsible":[111],"most":[113],"cervical":[114],"cancers.":[115],"VLP":[119,128],"(Merck":[121],"Research":[122],"Laboratories)":[123],"an":[125,363],"HPV-16/18":[126],"been":[133,204,513],"shown":[134],"prevent":[136],"corresponding":[140],"types.":[142],"In":[143,465,503],"double-blind,":[145],"placebo-controlled":[146],"trial,":[148],"GSK":[150],"induced":[152],"type-specific":[153],"antibody":[154],"responses":[155],"that":[156,409],"were":[157],"higher":[158],"than":[159],"elicited":[160],"by":[161,486],"natural":[162],"infections":[163,183],"resulted":[165],"incident":[169],"persistent":[171],"-18":[174],"infections.":[175],"Additional":[176],"challenges":[177],"include":[184,310,438],"assessing":[185],"duration":[187],"protection,":[189],"identifying":[190],"optimal":[191],"target":[192],"populations,":[193],"designing":[195],"implementation":[196],"strategies.\r\n\r\nCold-adapted,":[197],"strains":[200,221],"influenza":[202,223,242,295],"developed":[205],"United":[208],"States":[209],"(CAIV-T/USA)":[210],"Russia":[212],"(CAIV-T/Russia)":[213],"use":[215,395],"as":[216,362],"vaccines.":[217],"From":[218],"master":[219],"donor":[220],"B,":[226],"reassortant":[227,278],"viruses":[228,296,399],"can":[229,455],"be":[230,269,283,430],"produced":[231],"annually":[232],"contemporary":[234],"hemagglutinin":[235],"(HA)":[236],"neuraminidase":[238],"(NA)":[239],"from":[240,247],"wildtype":[241],"six":[244],"internal":[245],"genes":[246,408,476,488],"strains.":[250],"Reactogenicity":[251],"reassortants":[254],"is":[255,259,360],"generally":[256],"mild;":[257],"effectiveness":[258,458],"high.":[260],"Expanded":[261],"age":[262],"indications":[263],"expected.":[265],"Reverse":[266,280],"genetics":[267,281],"may":[268,426,428],"employed":[270],"future":[273],"rapidly":[275,299],"generate":[276],"PR-8\u2013based":[277],"could":[282,338],"used":[284],"eliminate":[286],"polybasic":[288],"cleavage":[289],"site":[290],"highly":[292,516],"pathogenic":[293],"avian":[294],"make":[300],"PR-8":[302],"reassortants.":[303],"approaches":[305],"trivalent":[307,373],"inactivated":[308,374],"high-dose":[311],"HA":[312,317,354,359],"synthesis":[314],"antigen,":[318,346],"addition":[319],"adjuvants,":[321],"intranasal":[323],"transdermal":[324],"administration":[325],"tissue":[327],"culture":[328,334],"production":[329,335,340],"whole":[331],"Tissue":[333],"antigen":[337],"shorten":[339],"time,":[341],"increase":[342],"quantity":[344],"exactly":[348],"match":[349],"genetic":[351],"sequence":[352],"circulating":[356],"Recombinant":[358],"effective":[361],"immunogen":[364],"would":[366],"reduce":[367],"reactogenicity":[369],"associated":[370],"egg-grown":[372],"vaccine.":[375],"Use":[376],"adjuvants":[378],"has":[379],"potential":[381],"stretch":[383],"supply":[386],"event":[389],"shortage.\r\n\r\nPlatform":[392],"technology":[393],"makes":[394],"live,":[397],"bacteria":[401,446],"express":[403],"one":[404],"more":[406],"foreign":[407],"encode":[410],"antigen(s)":[412],"interest":[414],"deliver":[416],"naked":[417],"encoding":[419,477],"antigen(s).":[422],"The":[423],"vector":[425,436,454,482],"replication":[431],"competent.":[432],"Examples":[433],"such":[435],"platforms":[437],"poxviruses,":[439],"adenoviruses,":[440],"alphavirus":[441],"replicons,":[442],"flaviviruses,":[443],"enteric":[445],"(e.g.,":[447],"Salmonella,":[448],"Lactobacillus).":[449],"Preexisting":[450],"immunity":[451],"limit":[456],"this":[460],"approach,":[461],"except":[462],"flaviviruses.":[464],"flavivirus":[466],"vectors,":[467],"e.g.,":[468,491],"yellow":[469],"fever":[470],"17":[471],"vaccine-virus":[473],"platform,":[474],"antigens":[479],"entirely":[484],"replaced":[485],"interest,":[490],"West":[492],"Nile":[493],"virus,":[494],"St.":[495],"Louis":[496],"encephalitis,":[497,499],"Japanese":[498],"dengue":[501],"virus.":[502],"clinical":[504,519],"trials,":[505],"several":[506],"these":[508],"chimeric":[509],"viral":[510],"well-tolerated":[514],"immunogenic":[517],"trials.":[520]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2016-06-24T00:00:00"}